SSTR4 agonist salts
US11834435B2 · kind B2 · utility
0Cited by
15References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2022 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Sep 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,1-dimethyl-2-[(3-methyl-2-pyridyl)oxy]ethyl]-3-azabicyclo[3.1.0]hexane-6-carboxamide, to pharmaceutical compositions comprising said salts, to methods of using said salts to treat physiological disorders, and to intermediates useful in the synthesis of the salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.